AZ’ roxadustat successful in late-stage trial
admin 25th July 2019 Uncategorised 0The trial met its primary efficacy endpoint of a mean change in haemoglobin from baseline averaged over weeks 23-27.
More: AZ’ roxadustat successful in late-stage trial
Source: News
